NCT06007690 2026-03-02
CoMpass
Aura Biosciences
Phase 3 Recruiting
Clinical Trials
6 trialsNCT07421739 2026-02-19
Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects
Aura Biosciences
Recruiting
NCT07136181 2025-11-28
NBM-BMX-UM
Novelwise Pharmaceutical Corporation
Phase 1/2 Recruiting
NCT05415072 2025-07-20
A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas
Novartis
Phase 1/2 Active not recruiting
NCT04417530 2025-03-03
Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma
Aura Biosciences
Phase 2 Completed
NCT03052127 2024-02-01
Study in Subjects With Small Primary Choroidal Melanoma
Aura Biosciences
Phase 1/2 Completed